ASML vs RYTM · P/E 57, $665.37B cap vs rev $130.1M
ASML Holding NV ADR (ASML) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the ASML and RYTM stock pages for the full models.
Not investment advice.